Phathom Pharmaceuticals Inc. (PHAT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Phathom Pharmaceuticals I...

    NASDAQ: PHAT · Real-Time Price · USD
    11.78
    0.12 (1.03%)
    At close: Sep 26, 2025, 3:59 PM
    11.76
    -0.17%
    After-hours: Sep 26, 2025, 07:11 PM EDT

    Phathom Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 55.25M 682K n/a n/a
    Cost of Revenue
    		 7.97M 167K 620K 521K
    Gross Profit
    		 47.28M 515K -620K -521K
    Operating Income
    		 -277.47M -167.31M -172.44M -135.08M
    Interest Income
    		 15.16M 7.88M 2.13M 41K
    Pretax Income
    		 -334.33M -201.59M -197.72M -143.88M
    Net Income
    		 -334.33M -201.59M -223.01M -148.09M
    Selling & General & Admin
    		 290.66M 117.93M 101M 62.74M
    Research & Development
    		 34.08M 49.9M 71.44M 72.34M
    Other Expenses
    		 n/a n/a -110K n/a
    Operating Expenses
    		 324.75M 167.83M 172.44M 135.08M
    Interest Expense
    		 72.01M 41.97M 27.3M 6.79M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 332.72M 167.99M 172.44M 135.08M
    Income Tax Expense
    		 n/a n/a 25.28M 4.21M
    Shares Outstanding (Basic)
    		 63.18M 51.29M 39.12M 37M
    Shares Outstanding (Diluted)
    		 63.18M 51.29M 39.12M 37M
    EPS (Basic)
    		 -5.29 -3.93 -5.7 -4
    EPS (Diluted)
    		 -5.29 -3.93 -5.7 -4
    EBITDA
    		 -261.52M -159.05M -171.82M -134.56M
    EBIT
    		 -262.32M -159.62M -170.42M -137.09M
    Depreciation & Amortization
    		 795K 575K 620K 521K

    Add to Watchlist